Nutritional Optimization for Heart Failure
(ENOL Trial)
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to assess whether a peri-operative intervention with nutritional immune modulating intervention (Ensure Surgery Immunonutrition shake) has beneficial effects on the complex interplay between gut microbiome, systemic inflammation and malnutrition that is commonly present in advanced heart failure and the adverse events associated with left ventricular assist device (LVAD) placement in hospitalized advanced heart failure patients awaiting LVAD implantation. The main questions it aims to answer are: * Will pre-surgical supplementation with Ensure Surgery affect gut microbial composition and levels of inflammation among heart failure patients undergoing LVAD implantation? * Will pre-surgical supplementation with Ensure Surgery affect post-surgical morbidity (e.g., infections, intensive care unit length of stay (LOS)) and mortality? Participants will be evaluated for malnutrition and will be given Ensure Surgery Immunonutrition shake to drink in the days preceding their LVAD surgery. Blood and stool samples will be collected at prespecified timepoints before and after surgery. Researchers will compare malnourished participants drinking Ensure Surgery 3/day with well-nourished participants randomized to drink either 1/day or 3/day to see if any of the above supplementation strategies change the gut microbial composition, levels of inflammation, and post-surgical morbidity and mortality.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Ensure Surgery Immunonutrition shake and related drinks for heart failure?
Is the nutritional treatment generally safe for humans?
How does the Nutritional Optimization for Heart Failure treatment differ from other treatments for heart failure?
The Nutritional Optimization for Heart Failure treatment is unique because it focuses on optimizing nutrition, potentially using specialized nutritional supplements, to support heart health, unlike traditional heart failure treatments that primarily involve medications or surgical interventions. This approach may include components like arginine-enriched supplements, which have shown benefits in surgical recovery, suggesting a novel way to manage heart failure by enhancing the body's nutritional status.14589
Research Team
Melana Yuzefpolskaya, MD
Principal Investigator
Columbia University
Eligibility Criteria
This trial is for adults over 18 with advanced heart failure who are hospitalized and awaiting LVAD implantation. They must be able to eat by mouth and not have congenital heart disease, infiltrative cardiomyopathy, or require intubation. Surgery should not be expected within the next 5 days.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-operative Nutritional Intervention
Participants receive Ensure Surgery Immunonutrition shake to optimize nutritional status before LVAD implantation
Surgery and Immediate Post-operative
Participants undergo LVAD implantation and are monitored for immediate post-operative outcomes
Follow-up
Participants are monitored for safety and effectiveness after discharge, including changes in biomarkers and microbiome
Treatment Details
Interventions
- Ensure Surgery Immunonutrition shake (Dietary Supplement)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor
Abbott Nutrition
Industry Sponsor